Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19

BACKGROUND: High incidence of cardiovascular events has been described among patients with COVID-19 and since the beginning of the pandemic concerns have been expressed with medical treatments for cardiovascular disease, as they could contribute to the severity of illness in patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Esteban-Lucia, L, Zambrano Chacon, M A, Venegas Rodriguez, A M, Devesa-Arbiol, A, Gonzalez-Rodriguez, M, Maure-Blesa, L, Avila-Barahona, P, Pello-Lazaro, A M, Gonzalez-Lorenzo, O, Kallmeyer-Mayor, A M, Fernandez-Roblas, R, Villar-Alvarez, F, Tunon, J, Acena Navarro, A, Franco-Pelaez, J A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Abstract Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767614/
http://dx.doi.org/10.1093/eurheartj/ehab724.3006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767614/
http://dx.doi.org/10.1093/eurheartj/ehab724.3006

Ejemplares similares